CompanyRIGLNasdaqSouth San Francisco, CA

Rigel Pharmaceuticals Inc

Rigel Pharmaceuticals develops small-molecule therapies for hematologic disorders and cancer.

SEC EDGAR ClinicalTrials.gov rigel.com

SCHEDULE 13G/AAug 14Latest SEC filing

Aug 4Latest story

August 2026

Rigel adds VEPPANU to portfolio, keeps R289 timeline, raises 2026 revenue guidance

Aug 4Quarterly updateRigel Pharmaceuticals Inc vepdegestrant

July 2026

Rigel Pharmaceuticals names Alison Hannah as new chief medical officer

Jul 1PeopleRigel Pharmaceuticals Inc